Bought
~$50K5,592 sh @ $8.92
Traded Mar 27 · filed 3 days later
A Lenz Therapeutics director paid $50K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month.
Loading…
Traded Mar 27, 2026 · Filed Mar 30, 2026
The CEO of Lenz Therapeutics paid $251K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. The Lenz Therapeutics shares held grew by 57%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$251,411
Shares × reported transaction price
$100K–$500K
+57.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of Mar 24, 2026, 45 days before results of May 11, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Mar 27 · filed 3 days later
A Lenz Therapeutics director paid $50K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month.
Traded Mar 27 · filed 3 days later
The CFO of Lenz Therapeutics paid $64K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. The Lenz Therapeutics shares held grew by 139%.
Traded Jan 2 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.